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in the peritoneal waste in a
patient treated with peritoneal
dialysis”
To the editor: We read with interest the letter from Vischini
et al. about the presence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) in the peritoneal effluent of a
peritoneal dialysis (PD) patient.1 Coronavirus transmission
occurs primarily via respiratory droplets, and it has been
found inconsistently in body secretions and excretions.2 SARS-
CoV-2 virion is 60–140 nanometers and could theoretically
enter the peritoneal cavity via hematogenous diffusion or
through the PD catheter after touch contamination.
This observation of Vischini et al. if confirmed, is
important for daily clinical care of PD patients and handling
of effluents. However, they found positive polymerase chain
reaction tests in PD effluents in their patient 1 month after
the first symptoms, calling into question whether the virus
itself was present or whether it was just noncontagious RNA
fragments. In our experience with serial PD effluent sam-
plings from 3 PD patients with mild to moderate active
coronavirus disease 2019 (COVID-19), we found results
discordant with those of Vischini et al. We used quantitative
reverse transcription polymerase chain reaction analysis based
on the highly specific RdRp gene and E gene, in 2 independent
laboratories. Although nasopharyngeal swabs obtained at
admission showed high viral load in all 3 patients (cycle
threshold value <30), decreasing during hospitalization, none
of the 11 PD effluent samplings at days 0–3–4–7 taken after a
12-hour dwell time tested positive, even after dialysate
centrifugation. A blood sample was positive in only one pa-
tient (A. Candellier, A. Scohy, N. Gillet, et al., submitted for512publication, 2020). Our data are also in line with the absence
of SARS RNA in effluents from PD patients with SARS
infection.3
The opposite results for both observations argue for per-
forming a SARS-CoV-2 culture to confirm PD effluent conta-
giousness before imposing specific procedures in PD patients.
1. Vischini G, D’Alonzo S, Grandaliano G, D’Ascenzo FM. SARS-CoV-2 in the
peritoneal waste in a patient treated with peritoneal dialysis. Kidney Int.
2020;98:237–238.
2. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of
clinical specimens. JAMA. 2020;323:1843–1844.
3. Kwan BC-H, Leung C-B, Szeto C-C, et al. Severe acute respiratory syndrome
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trends in South Korea
during the COVID-19 pandemic
To the editor: We read with interest the article by Banerjee
et al.1 reporting 7 cases of coronavirus disease 2019 (COVID-
19) in kidney transplant recipients. Banerjee et al.1 raised
concerns about increased susceptibility to COVID-19
infection during the postoperative period; however, the
impact of immunosuppression on susceptibility to COVID-
19 remains unknown. Recent data on clinical outcomes of
COVID-19 infection in kidney transplant patients are
conflicting.2 Furthermore, some preliminary reports suggest
the reduced immune response due to immunosuppression
may provide a protective effect against severe COVID-19.3
South Korea was one of the earliest countries to experience
the COVID-19 outbreak, quickly becoming the country with
the second highest number of COVID-19 infections after
China. In response, South Korea carried out extensive virus
testing and contact tracing. In cooperation with national-level
efforts, most transplant programs adopted universal donor
and recipient screening using reverse transcriptase polymer-
ase chain reaction, in accordance with the Korean Trans-
plantation Society recommendation. Thus, national kidney
transplant activities in South Korea remained stable for both
living and deceased donor transplantation compared with the
same period during the previous year (Table 1).
During these unprecedented times, little is known about
the safety of kidney transplantation. However, delaying or
halting of kidney transplantation is not a safe option for
patients with end-stage renal disease. Because they stillKidney International (2020) 98, 505–516















Living donor 493 (65.1) 473 (61.1) 4.1
Deceased
donor
264 (34.9) 301 (38.9) þ14.0
Age, yr
<40 152 (20.1) 145 (18.7) 4.6
40–49 178 (23.5) 190 (24.6) þ6.7
50–59 278 (36.7) 249 (32.2) 10.4
50–69 134 (17.7) 169 (21.8) þ26.1
$70 15 (2.0) 21 (2.7) þ40.0
COVID-19, coronavirus disease 2019.
























































































































































































































































































































































































































































































































































































































































































l e t t e r s to the ed i to rrequire lifesaving dialysis during the pandemic, these
vulnerable patients are unable to practice social distancing
and must travel to dialysis facilities.4 Therefore, we should
carefully weigh the risks and benefits of pursuing or
postponing kidney transplantation, considering immediate
medical circumstances.
1. Banerjee D, Popoola J, Shah S, et al. COVID-19 infection in kidney
transplant recipients. Kidney Int. 2020;97:1076–1082.
2. The Columbia University Kidney Transplant Program. Early description of
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eaUnusually high rates of








































































































e.COVID-19 pandemic: cause for
concern?
To the editor: The coronavirus disease 2019 (COVID-19)
pandemic has caused unprecedented health care, eco-
nomic, and psychosocial crises. We report a case series of
6 kidney and pancreas transplant recipients who presentedKidney International (2020) 98, 505–516 513
